Chicago, IL – According to filings with the U.S. Securities and Exchange Commission, SkinIO is raising $1,500,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Kyoko Crawford played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About SkinIO

The challenge of skin cancer is not that there isn’t a cure; it is that we are not detecting skin cancer early enough in too many cases. At SkinIO, our mission is to make skin cancer screening and skin health monitoring accessible, whether at the doctor’s office or in the comfort of home. SkinIO has developed an affordable total body photography solution that allows health care providers to offer automated, AI-enabled mole mapping in any exam room in their office. With contextual dermoscopic image linking and the ability to track changes over time, dermatologists are able to offer the best possible care for their patients. SkinIO has now expanded into teledermatology to enable more convenient patient-physician interactions.

To learn more about SkinIO, visit http://www.skinio.com/

Contact:
Kyoko Crawford, Chief Executive Officer
917-670-0821
https://www.linkedin.com/in/kyokocrawford/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved